![Susan Blum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Blum
Director of Finance/CFO at
CORMEDIX INC.
Net worth: 1 M $ as of 2026-06-29
Profile
Susan Blum is Chief Financial Officer & Executive Vice President at CorMedix, Inc. since 2025.
Formerly, Ms. Blum was Independent Director at BiomX, Inc. from 2024 to 2026, Chief Financial Officer at Melinta Therapeutics, Inc. from 2021 to 2025, and Controller at Textura Corp.
from 2013 to 2016.
Ms. Blum completed undergraduate education at Santa Clara University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CORMEDIX INC. 0.17% | 2026-01-22 | 132,739 ( 0.17% ) | 1 M $ | 2026-06-29 |
Susan Blum active positions
| Companies | Position | Start |
|---|---|---|
| CORMEDIX INC. | Director of Finance/CFO | 2025-08-28 |
Former positions of Susan Blum
| Companies | Position | End |
|---|---|---|
| BIOMX INC. | Director/Board Member | 2026-02-23 |
| MELINTA THERAPEUTICS, INC. | Director of Finance/CFO | 2025-08-28 |
| TEXTURA CORP | Comptroller/Controller/Auditor | 2015-12-31 |
Training of Susan Blum
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
26
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
CorMedix, Inc.
 CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Textura Corp.
 Textura Corp. Packaged SoftwareTechnology Services Develops software for real estate developers and contractors construction projects | Technology Services |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
BiomX, Inc.
 BiomX, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company developing natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin | Health Technology |
- Stock Market
- Insiders
- Susan Blum
Choose MarketScreener 
